Published on
November 22, 2024
- 02:00 GMT

Precision Epigenomics Shares Abstracts Showing Performance of Assays for Melanoma and Brain Cancer Detection
Precision Epigenomics announced that the company presented data supporting the critical role of its melanoma classifier. TUCSON, AZ, UNITED STATES, November 21, 2024 /EINPresswire.com/ -- Precision Epigenomics, the developer of the EPISEEK™ multi-cancer …
Distribution channels:
Business & Economy, Culture, Society & Lifestyle
...